Business · 1 sources covering this

Natco Pharma Q2 Results: Net Profit Falls 61% To Rs 203 Crore, Revenue Declines 29%; Stock Tumbles 3%

At the operating level, earnings before interest, taxes, depreciation and amortisation (EBITDA) fell 55.4% to Rs 258.3 crore, compared with Rs 579 crore a year ago.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

NDTVCenter·2h ago
Natco Pharma Q2 Results: Net Profit Falls 61% To Rs 203 Crore, Revenue Declines 29%; Stock Tumbles 3%
At the operating level, earnings before interest, taxes, depreciation and amortisation (EBITDA) fell 55.4% to Rs 258.3 crore, compared with Rs 579 crore a year ago.
Read at NDTV →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/a524bb2aaa64ceee39d39f58cba94b5f6f25dc4e"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Natco Pharma Q2 Results: Net Profit Falls 61% To Rs 203 Crore, Revenue Declines 29%; Stock Tumbles 3%"></iframe>

Natco Pharma Q2 Results: Net Profit Falls 61% To Rs 203 Crore, Revenue Declines 29%; Stock Tumbles 3%

How 1 sources are covering this

Natco Pharma Q2 Results: Net Profit Falls 61% To Rs 203 Crore, Revenue Declines 29%; Stock Tumbles 3%

More from Business

UWB: Soon, technology behind AirTag could do more than find lost things

India's trade deficit at 12-month high as October imports hit record

Paytm gets RBI prelim nod to operate wallets; shares surge to 52-week high

Paytm gets RBI preliminary nod for wallet, other pre-paid instruments

Reader

Trust & legal

Across the network